Eye Disease Drugmaker’s Value Halved After Severe Reactions
Apellis Pharmaceuticals Inc. shares suffered their worst two-day drop on record after confirming reports that some patients experienced
2023-07-19 04:21
Europe Braces for Record Heat as Wildfires Hit Greece
The extreme heat blanketing the Mediterranean is set to peak in parts of Italy on Tuesday, triggering fresh
2023-07-18 21:21
Lockheed Martin raises full-year forecast on strong weapons demand
By Pratyush Thakur and Mike Stone (Reuters) -U.S. weapons maker Lockheed Martin on Tuesday raised its annual profit and sales
2023-07-18 19:48
Deutsche Bank cuts China's 2023 growth forecast to 5.3%
Deutsche Bank lowered its forecast for China's economic growth forecast this year to 5.3%, from 6% earlier, citing
2023-07-18 15:28
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in
2023-07-18 13:57
China Foreign Minister’s Mystery Absence Fuels Black Box Concern
The mystery three-week absence of China’s Foreign Minister Qin Gang, considered a rising star of Chinese politics, is
2023-07-18 12:59
Is the worst over for Sri Lanka's economic crisis?
A year after the start of the crisis, life looks normal in Colombo but is the country out of the woods?
2023-07-18 07:46
Medicare Proposes Expanding Patient Access to Alzheimer’s Scans
The US Medicare program will roll back rules that limited coverage for an expensive imaging scan for people
2023-07-18 06:25
Why celebrities are striking: The average pay for actors may surprise you
On Friday, SAG-AFTRA officially went on strike after failing to reach a deal with Hollywood's biggest studios. Actors on strike are calling for increased pay and a rethinking of how residuals are paid out when shows are aired on streaming services.
2023-07-18 02:27
Astra, Sanofi RSV Drug Approved in US for Use in Infants
AstraZeneca Plc and Sanofi’s drug for RSV in infants was approved in the US, the first-ever preventive intended
2023-07-18 01:24
Lilly Applies for Alzheimer’s Drug’s US Approval After Trial Success
Eli Lilly & Co. said it applied for full US approval of its Alzheimer’s disease drug that’s expected
2023-07-17 22:51
HSBC Votes Against Big Oil More Often Than Peers, Analysis Shows
The investment arm of HSBC Holdings Plc is ahead of peers in backing shareholder resolutions designed to force
2023-07-17 13:17